Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu, Ruiyuan Cao, Mingyue Xu, Xi Wang, Huanyu Zhang, Hengrui Hu, Yufeng Li, Zhihong Hu, Wu Zhong, Manli Wang
Cell Discovery, doi:10.1038/s41421-020-0156-0
Dear Editor, The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/2019-nCoV) poses a serious threat to global public health and local economies. As of March 3, 2020, over 80,000 cases have been confirmed in China, including 2946 deaths as well as over 10,566 confirmed cases in 72 other countries. Such huge numbers of infected and dead people call for an urgent demand of effective, available, and affordable drugs to control and diminish the epidemic. We have recently reported that two drugs, remdesivir (GS-5734) and chloroquine (CQ) phosphate, efficiently inhibited SARS-CoV-2 infection in vitro 1 . Remdesivir is a nucleoside analog prodrug developed by Gilead Sciences (USA). A recent case report showed that treatment with remdesivir improved the clinical condition of the first patient infected by SARS-CoV-2 in the United States 2 , and a phase III clinical trial of remdesivir against SARS-CoV-2 was launched in Wuhan on February 4, 2020. However, as an experimental drug, remdesivir is not expected to be largely available for treating a very large number of patients in a timely manner. Therefore, of the two potential drugs, CQ appears to be the drug of choice for large-scale use due to its availability, proven safety record, and a relatively low cost. In light of the preliminary clinical data, CQ has been added to the list of
Conflict of interest The authors declare that they have no conflict of interest. Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary Information accompanies the paper at (https://doi.org/ 10.1038/s41421-020-0156-0).
References
Huang, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet
Laaksonen, Koskiahde, Juva, Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine, Scand. J. rheumatol
Mauthe, Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion, Autophagy
Mcchesney, Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate, Am. J. Med
Mingo, Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step, J. Virol
Ohkuma, Poole, Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents, Proc. Natl Acad. Sci
Popert, Choloroquine: a review, Rheumatology
Savarino, New insights into the antiviral effects of chloroquine, Lancet Infect. Dis
Wang, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res
Weniger, Review of side effects and toxicity of chloroquine, Bull. World Health
Zheng, Zhang, Rosania, Effect of phospholipidosis on the cellular pharmacokinetics of chloroquine, J. Pharmacol. Exp. Ther
{ 'indexed': {'date-parts': [[2024, 5, 14]], 'date-time': '2024-05-14T18:41:39Z', 'timestamp': 1715712099827},
'reference-count': 12,
'publisher': 'Springer Science and Business Media LLC',
'issue': '1',
'license': [ { 'start': { 'date-parts': [[2020, 3, 18]],
'date-time': '2020-03-18T00:00:00Z',
'timestamp': 1584489600000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0'},
{ 'start': { 'date-parts': [[2020, 3, 18]],
'date-time': '2020-03-18T00:00:00Z',
'timestamp': 1584489600000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0'}],
'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False},
'DOI': '10.1038/s41421-020-0156-0',
'type': 'journal-article',
'created': {'date-parts': [[2020, 3, 18]], 'date-time': '2020-03-18T03:03:16Z', 'timestamp': 1584500596000},
'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy',
'source': 'Crossref',
'is-referenced-by-count': 1364,
'title': 'Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting '
'SARS-CoV-2 infection in vitro',
'prefix': '10.1038',
'volume': '6',
'author': [ {'given': 'Jia', 'family': 'Liu', 'sequence': 'first', 'affiliation': []},
{'given': 'Ruiyuan', 'family': 'Cao', 'sequence': 'additional', 'affiliation': []},
{'given': 'Mingyue', 'family': 'Xu', 'sequence': 'additional', 'affiliation': []},
{'given': 'Xi', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []},
{'given': 'Huanyu', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []},
{'given': 'Hengrui', 'family': 'Hu', 'sequence': 'additional', 'affiliation': []},
{'given': 'Yufeng', 'family': 'Li', 'sequence': 'additional', 'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-1560-0928',
'authenticated-orcid': False,
'given': 'Zhihong',
'family': 'Hu',
'sequence': 'additional',
'affiliation': []},
{'given': 'Wu', 'family': 'Zhong', 'sequence': 'additional', 'affiliation': []},
{'given': 'Manli', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}],
'member': '297',
'published-online': {'date-parts': [[2020, 3, 18]]},
'reference': [ { 'key': '156_CR1',
'doi-asserted-by': 'publisher',
'first-page': '269',
'DOI': '10.1038/s41422-020-0282-0',
'volume': '30',
'author': 'M Wang',
'year': '2020',
'unstructured': 'Wang, M. et al. Remdesivir and chloroquine effectively inhibit the '
'recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30, '
'269–271 (2020).',
'journal-title': 'Cell Res.'},
{ 'key': '156_CR2',
'doi-asserted-by': 'publisher',
'DOI': '10.1056/NEJMoa2001191',
'author': 'ML Holshue',
'year': '2020',
'unstructured': 'Holshue, M. L. et al. First case of 2019 novel coronavirus in the United '
'States. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2001191 (2020).',
'journal-title': 'N. Engl. J. Med.'},
{ 'key': '156_CR3',
'first-page': '906',
'volume': '79',
'author': 'H Weniger',
'year': '1979',
'unstructured': 'Weniger, H. Review of side effects and toxicity of chloroquine. Bull. '
'World Health 79, 906 (1979).',
'journal-title': 'Bull. World Health'},
{ 'key': '156_CR4',
'doi-asserted-by': 'publisher',
'first-page': '11',
'DOI': '10.1016/0002-9343(83)91265-2',
'volume': '75',
'author': 'EW McChesney',
'year': '1983',
'unstructured': 'McChesney, E. W. Animal toxicity and pharmacokinetics of '
'hydroxychloroquine sulfate. Am. J. Med. 75, 11–18 (1983).',
'journal-title': 'Am. J. Med.'},
{ 'key': '156_CR5',
'doi-asserted-by': 'publisher',
'first-page': '1435',
'DOI': '10.1080/15548627.2018.1474314',
'volume': '14',
'author': 'M Mauthe',
'year': '2018',
'unstructured': 'Mauthe, M. et al. Chloroquine inhibits autophagic flux by decreasing '
'autophagosome-lysosome fusion. Autophagy 14, 1435–1455 (2018).',
'journal-title': 'Autophagy'},
{ 'key': '156_CR6',
'doi-asserted-by': 'publisher',
'first-page': '67',
'DOI': '10.1016/S1473-3099(06)70361-9',
'volume': '6',
'author': 'A Savarino',
'year': '2006',
'unstructured': 'Savarino, A. et al. New insights into the antiviral effects of '
'chloroquine. Lancet Infect. Dis. 6, 67–69 (2006).',
'journal-title': 'Lancet Infect. Dis.'},
{ 'key': '156_CR7',
'doi-asserted-by': 'publisher',
'first-page': '2931',
'DOI': '10.1128/JVI.03398-14',
'volume': '89',
'author': 'RM Mingo',
'year': '2015',
'unstructured': 'Mingo, R. M. et al. Ebola virus and severe acute respiratory syndrome '
'coronavirus display late cell entry kinetics: evidence that transport to '
'NPC1+ endolysosomes is a rate-defining step. J. Virol. 89, 2931–2943 '
'(2015).',
'journal-title': 'J. Virol.'},
{ 'key': '156_CR8',
'doi-asserted-by': 'publisher',
'first-page': '661',
'DOI': '10.1124/jpet.110.175679',
'volume': '336',
'author': 'N Zheng',
'year': '2011',
'unstructured': 'Zheng, N., Zhang, X. & Rosania, G. R. Effect of phospholipidosis on the '
'cellular pharmacokinetics of chloroquine. J. Pharmacol. Exp. Ther. 336, '
'661–671 (2011).',
'journal-title': 'J. Pharmacol. Exp. Ther.'},
{ 'key': '156_CR9',
'doi-asserted-by': 'publisher',
'first-page': '3327',
'DOI': '10.1073/pnas.75.7.3327',
'volume': '75',
'author': 'S Ohkuma',
'year': '1978',
'unstructured': 'Ohkuma, S. & Poole, B. Fluorescence probe measurement of the '
'intralysosomal pH in living cells and the perturbation of pH by various '
'agents. Proc. Natl Acad. Sci. USA 75, 3327–3331 (1978).',
'journal-title': 'Proc. Natl Acad. Sci. USA'},
{ 'key': '156_CR10',
'doi-asserted-by': 'publisher',
'first-page': '235',
'DOI': '10.1093/rheumatology/15.3.235',
'volume': '15',
'author': 'AJ Popert',
'year': '1976',
'unstructured': 'Popert, A. J. Choloroquine: a review. Rheumatology 15, 235–238 (1976).',
'journal-title': 'Rheumatology'},
{ 'key': '156_CR11',
'doi-asserted-by': 'publisher',
'first-page': '103',
'DOI': '10.3109/03009747409115809',
'volume': '3',
'author': 'AL Laaksonen',
'year': '1974',
'unstructured': 'Laaksonen, A. L., Koskiahde, V. & Juva, K. Dosage of antimalarial drugs '
'for children with juvenile rheumatoid arthritis and systemic lupus '
'erythematosus. A clinical study with determination of serum '
'concentrations of chloroquine and hydroxychloroquine. Scand. J. '
'rheumatol. 3, 103–108 (1974).',
'journal-title': 'Scand. J. rheumatol.'},
{ 'key': '156_CR12',
'doi-asserted-by': 'publisher',
'first-page': '497',
'DOI': '10.1016/S0140-6736(20)30183-5',
'volume': '395',
'author': 'C Huang',
'year': '2020',
'unstructured': 'Huang, C. et al. Clinical features of patients infected with 2019 novel '
'coronavirus in Wuhan, China. Lancet 395, 497–506 (2020).',
'journal-title': 'Lancet'}],
'container-title': 'Cell Discovery',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://www.nature.com/articles/s41421-020-0156-0.pdf',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://www.nature.com/articles/s41421-020-0156-0',
'content-type': 'text/html',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://www.nature.com/articles/s41421-020-0156-0.pdf',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2022, 12, 5]],
'date-time': '2022-12-05T16:04:30Z',
'timestamp': 1670256270000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.nature.com/articles/s41421-020-0156-0'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2020, 3, 18]]},
'references-count': 12,
'journal-issue': {'issue': '1', 'published-online': {'date-parts': [[2020, 12]]}},
'alternative-id': ['156'],
'URL': 'http://dx.doi.org/10.1038/s41421-020-0156-0',
'relation': { 'has-review': [ { 'id-type': 'doi',
'id': '10.3410/f.737576290.793575077',
'asserted-by': 'object'}]},
'ISSN': ['2056-5968'],
'subject': [],
'container-title-short': 'Cell Discov',
'published': {'date-parts': [[2020, 3, 18]]},
'assertion': [ { 'value': '24 February 2020',
'order': 1,
'name': 'received',
'label': 'Received',
'group': {'name': 'ArticleHistory', 'label': 'Article History'}},
{ 'value': '4 March 2020',
'order': 2,
'name': 'accepted',
'label': 'Accepted',
'group': {'name': 'ArticleHistory', 'label': 'Article History'}},
{ 'value': '18 March 2020',
'order': 3,
'name': 'first_online',
'label': 'First Online',
'group': {'name': 'ArticleHistory', 'label': 'Article History'}},
{ 'value': 'The authors declare that they have no conflict of interest.',
'order': 1,
'name': 'Ethics',
'group': {'name': 'EthicsHeading', 'label': 'Conflict of interest'}}],
'article-number': '16'}